Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2025-12-25 @ 3:02 PM
NCT ID: NCT01144468
Description: Women discontinued the study if their lumbar spine, total hip, or femoral neck areal BMD dropped 10% or more in the preceding year, their T-scores fell to or below -2ยท5, or if they sustained fragility fractures or started taking drugs for bone-related disorders
Frequency Threshold: 0
Time Frame: 2 years
Study: NCT01144468
Study Brief: Effects of Exemestane on Bone Strength
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
MAP3 Participants on 25 mg Exemestane Daily MAP3 treatment arm 0 None 0 176 3 176 View
MAP3 Participants on Placebo MAP3 placebo arm 0 None 0 175 2 175 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Bone related adverse event SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View